Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OSL/CRNA stock hub

OSL/CRNA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OSL/CRNAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.3B

Oslo Børs

Market data

Live price

Current market quote for this ticker.

Current price

OSL/CRNA

In the news

Latest news · OSL/CRNA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-7,097.3

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OSL/CRNA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

141

Groups with data

Currency

NOK

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	NO
Employees	11
Employees Change	1%
Employees Change Percent	10
Enterprise value	NOK 2.3B
Exchange	Oslo Børs
Financial currency	NOK
First seen	2026-05-10
Industry	Biotechnology
Isin	NO0013033795
Last refreshed	2026-05-10
Market cap	NOK 2.3B
Price	NOK 9.52
Price currency	NOK
Sector	Healthcare
Sic	2836
Symbol	osl/CRNA
Website	https://www.circio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.03%
EV Earnings	-49.42x
P/B ratio	-181.42x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	NOK -45.9M
Profit Per Employee	NOK -4.6M
ROA	-157.5
Roa5y	-94.39
ROCE	328.6
ROIC	-7,097.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-26.84%
Cagr1y	1,307.09%
Cagr3y	-16.68%
Cagr5y	-42.54%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	NOK 10.8M
Cash	NOK 6.1M
Current Assets	NOK 10.6M
Current Liabilities	NOK 23.2M
Debt	NOK 8.4M
Equity	NOK -12.5M
Interest Coverage	-242.9
Liabilities	NOK 23.2M
Long Term Assets	NOK 176,000
Long Term Liabilities	NOK 0
Net Cash	NOK -2.2M
Net Cash By Market Cap	NOK -0.1
Tangible Book Value	NOK -12.5M
Tangible Book Value Per Share	NOK -0.09
WACC	-2.47

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.46
Net Working Capital	NOK -10.4M
Quick ratio	0.46
Working Capital	NOK -12.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-406.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-95.6%
1Y total return	1,304.54%
200-day SMA	2.5
3Y total return	-42.15%
50-day SMA	7.1
50-day SMA vs 200-day SMA	50over200
5Y total return	-93.73%
All Time High	1,017
All Time High Change	-99.06%
All Time High Date	2017-03-06
All Time Low	0.48
All Time Low Change	1,883.33%
All Time Low Date	2025-03-14
ATR	1.13
Beta	-1.22
Beta1y	-4.09
Beta2y	-3.16
Ch YTD	717.9
High	9.63
High52	14.46
High52 Date	2026-04-07
High52ch	-34.16%
Low	8.71
Low52	0.55
Low52 Date	2025-08-13
Low52ch	1,640.4%
Ma50ch	34.1%
Price vs 200-day SMA	280.65%
RSI	56.25
RSI Monthly	50.89
RSI Weekly	72.28
Sharpe ratio	2.16x
Sortino ratio	5.82
Total Return	-406.22%
Tr YTD	744.7
Tr1m	-33.89%
Tr1w	5.78%
Tr3m	775%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NOK -41.1M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	199,113,869%
Net Borrowing	37,715,000
Shares Insiders	6.34%
Shares Institutions	5.68%
Shares Out	238,054,835
Shares Qo Q	44.39%
Shares Yo Y	406.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	18,128,315.55x
Bv Per Share	-0.09
Ch10y	-97.12
Ch1m	-33.89
Ch1w	5.78
Ch1y	1,260
Ch3m	775
Ch3y	-46.21
Ch5y	-95.82
Ch6m	902.1
Change	7.57%
Change From Open	7.21
Close	8.85
Days Gap	0.34
Depreciation Amortization	25,000
Dollar Volume	78,722,555.5
Earnings Date	2026-04-15
EBIT	NOK -41.1M
EBITDA	NOK -41M
EPS	NOK -0.44
F Score	1
Financing CF	33,597,000
Fiscal Year End	December
Founded	2,010
Is Primary Listing	1
Last Earnings Date	2026-04-15
Last Report Date	2025-12-31
Last Split Date	2023-10-04
Last Split Type	Reverse
Ma150	3.13
Ma150ch	204.25%
Ma20	8.97
Ma20ch	6.1%
Net CF	-12,205,000
Next Earnings Date	2026-08-31
Open	8.88
Position In Range	88.04
Ppne	176,000
Price Date	2026-05-08
Relative Volume	0.47x
Share Based Comp	1,240,000
Tr6m	934.92%
Volume	8,269,176

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OSL/CRNA pay a dividend?

Capital-return profile for this ticker.

Performance

OSL/CRNA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns OSL/CRNA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.7%

Share of float held by funds and institutions

Insider ownership

+6.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+406.2%

Negative means the company is buying back shares.

Technical

OSL/CRNA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

56.2

Neutral momentum band

Price vs 200-day MA

+280.6%

50/200-day relationship not available

Beta (5Y)

-1.22

Less volatile than the market

Sharpe ratio

2.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OSL/CRNA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current osl/CRNA stock rating?

osl/CRNA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full osl/CRNA analysis?

The full report lives at /stocks/osl/CRNA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for osl/CRNA?

The latest report frames osl/CRNA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the osl/CRNA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.